Tamil Nadu Health and Family Welfare Department notifies the Tamil Nadu Clinical Establishments (Regulation) Rules, 2018, effective June 4, 2018
With a view to effectively implement the Tamil Nadu Clinical Establishments (Regulation) Act, 1997, the Health and Family Welfare Department, Tamil Nadu, has, through a...
Continue ReadingMinistry of Health and Family Welfare issues press release concerning circulation of inferior quality Polio Vaccines in the market
The Ministry of Health and Family Welfare has in a recent press release dated 3rd October, 2018, expressed concern over certain reports doing rounds that...
Continue ReadingCDSCO releases draft Guidelines to regulate and maintain quality, standards of pharmaceutical products, invites comments by October 16, 2018
The Central Drugs Standard Control Organization (“CDSCO”), in a Notice dated September 25, 2018, has published a draft copy of the Guidelines on Good Distribution Practices for...
Continue ReadingRules to implement provisions of the recently notified Human Immuno-Deficiency Virus and Acquired Immune Deficiency Syndrome (HIV) Act kicks in; gains effect 17th September, 2018
We have already reported that the Human Immuno-Deficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 (“Act”) is effective since 10th September 2018....
Continue ReadingTelangana Labour Department invites comments on the proposed revisions to the Minimum Wages for Clinics / Hospitals / Nursing Homes / Dispensaries by 27th October, 2018
The Labour, Employment, Training and Factories Department of the Telangana Government (“Department”) has in a notification dated 27thAugust 2018, invited comments/suggestions on the proposed revisions...
Continue ReadingCDSCO prohibits / restricts manufacture, sale and distribution of 328 Fixed Dose Combination Drugs (FDCs)
The Central Drugs Standard Control Organization (“CDSCO”) has prohibited manufacture, sale or distribution of 328 Fixed Drug Combinations (“FDCs”). The prohibition was imposed on 7th September...
Continue ReadingHuman Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 gains the force of law effective 10.09.2018
In a recent Notification No. S.O. 4715(E), the Central Government has finally given effect to the provisions of the Human Immunodeficiency Virus and Acquired Immune...
Continue ReadingCDSCO issues a list of spurious, adulterated, misbranded, or not of standard quality drugs and devices for the month of August, 2018
In the Safety Alert section of its official website, Central Drugs Standard Control Organization (“CDSCO”) has published a list of drugs, medical devices and cosmetics that...
Continue ReadingThe Atomic Energy Regulatory Board (AERB) establishes HELP DESK for providing regulatory support to users of Radiation Facilities
The Atomic Energy Regulatory Board has established a Help Desk for providing regulatory support to users of radiation facilities.The contact number of Help Desk is 022-2599 0675 and...
Continue ReadingDelhi HC stays Centre’s order preventing manufacture and sale of Oxytocin by Private manufacturers for a period of 1 month i.e. till 31.09.2018
The Delhi High Court has imposed a stay on the Central Government order banning the manufacture and sale of drugs containing oxytocin by private companies for...
Continue Reading